Gilead Sciences's total assets for Q2 2026 were $49.36B, a decrease of -12.29% from the previous quarter. MX:GILD total liabilities were $37.62B for the fiscal quarter, a 14.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.